Stunning PICS- Riverfront Passenger Jetty inaugurated at Bogibeel Road-cum-Railway Bridge
时间:2024-06-26 13:36:59 阅读(143)
The Government of India (GOI) has given a multimodal connectivity push in the north-east part of the country! On Monday, Railways’ Riverfront Passenger Jetty was inaugurated at Bogibeel Road-cum-Railway Bridge. By using the potential of the mighty Brahmaputra River, this will open new doors of opportunities.In Assam, the country’s longest river cruise service will begin in 2023. It will be between Varanasi and Bogibeel. It will traverse a distance of more than 4,000 km. Via Indo-Bangladesh Protocol Route (IBRP), the route will connect the rivers Ganga and Brahmaputra.For the people of both the states, the service will usher in an unexplored opportunity to use inland waterways for promoting their trade, tourism, and for cargo transportation. Here are some beautiful pictures. Have a look:2/5
Across the Brahmaputra river, the Government of India is also identifying avenues to promote inland navigation and river cruise tourism. (Image: Twitter/Ministry of Railways)
3/5The project to develop river site near the Bogibeel Bridge is a major step towards integrated connectivity between railways and waterways in India. (Image: Twitter/Ministry of Railways)
4/5It is being done under mission ‘Gati Shakti’ launched by Prime Minister Narendra Modi. (Image: Twitter/Ministry of Railways)
5/5The riverfront facility also has immense potential to evolve as a tourist hub in the north-east part of the country.(Image: Twitter/Ministry of Railways)
猜你喜欢
- s, especially those with taste changes or dietary limits, to stick with the treatment. In a nutshell, BDENZA ORAL SOLUTION is a simpler, more patient-friendly way to tackle prostate cancer. It can help improving the patient compliance to a great extent,” Dr. Aravind Badiger Director, Technical Formulation said in a statement.
BDENZA ORAL SOLUTION represents a significant advancement in prostate cancer therapy, offering relief and hope to millions of patients worldwide.
“BDENZA represents a paradigm shift in prostate cancer therapy. Its introduction aligns with our relentless pursuit to provide accessible and patient-centric healthcare solutions. This first-of-its-kind oral solution that addresses the challenges faced by many patients, offering convenience, reduced side effects, and a palatable sugar-free taste and affordability,” Raheel Shah, BDR Group Director (Business Development) said in a statement.
- Kotak Mahindra Bank pitches for standardising fraud reporting to RBI
- Adani Transmission, Adani Green Energy among 120 BSE stocks to touch 52-week lows, 112 stocks hit 52-week highs
- ALLEN Career Institute opens admissions for 2024-25 academic year with ASAT on January 7th
- Archean Chemicals, 2 other IPOs to hit Dalal Street next week to raise around Rs 4,280 crore; check details
- Biggest single-day gain for rupee in about a year
- Bombay Dyeing shares rise 20% on land deal; debt reduction plans
- Airox Technologies files Rs 750-cr IPO papers with Sebi
- L&T Infotech stock falls as earnings and dividend fail to entice investors; time to buy, sell, or hold-